Sivaprasad, Sobha
Chandra, Shruti
Sadda, SriniVas
Teo, Kelvin Y. C.
Thottarath, Sridevi
de Cock, Eduard
Empeslidis, Theo
Esmaeelpour, Marieh
Article History
Received: 29 May 2024
Accepted: 24 July 2024
First Online: 16 August 2024
Declarations
:
: Sobha Sivaprasad reports receiving financial support from AbbVie, Amgen, Apellis, Bayer, Biogen, Boehringer Ingelheim, Novartis, EyeBio, EyePoint Pharmaceuticals, Janssen Pharmaceuticals, Novo Nordisk, Optos, Ocular Therapeutix, Kriya Therapeutics, OcuTerra, Roche, Stealth BioTherapeutics, Sanofi. Shruti Chandra: None. SriniVas Sadda reports consulting fees from AbbVie, Alexion, Allergan Inc., Amgen Inc., Apellis Pharmaceuticals Inc., Astellas, Bayer HealthCare Pharmaceuticals, Biogen MA Inc., Boehringer Ingelheim, Centervue Inc., Character Bio., EyePoint Pharmaceuticals, Hoffman La Roche Ltd., Iveric Bio, Janssen Pharmaceuticals Inc., Nanoscope, Neurotech Pharmaceuticals Inc., Notal Vision Inc., Ocular Therapeutix, Inc., Optos Inc., Pfizer Inc., Regeneron Pharmaceuticals Inc., Samsung Bioepis, Heidelberg Engineering, Novartis Pharma AG, and Topcon Medical Systems Inc.; payment or honoraria for lectures, presentations, speaker bureaus, manuscript writing or educational events from Heidelberg Engineering, Hoffman La Roche Ltd., Nidek Incorporated, Novartis Pharma AG, and Optos Inc.; participation on a data safety monitoring board or advisory board for Regeneron Pharmaceuticals Inc., and REGENXBIO; leadership or fiduciary role in other board, society, committee or advocacy group for the Association for Research in Vision and Ophthalmology (unpaid: president/board of trustees) and Macula Society (unpaid: president); and receipt of equipment from Carl Zeiss Meditec AG, Heidelberg Engineering, iCare, Nidek Incorporated, Optos Inc., and Topcon Medical Systems Inc. Kelvin YC Teo reports consultancy fees, honoraria, travel support and speaker fees from Bayer, Roche, TopCon, Carl Zeiss, Boehringer Ingelheim and Novartis. Sridevi Thottarath: None. Eduard de Cock, Theo Empeslidis and Marieh Esmaeelpour are employees of Boehringer Ingelheim.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.